These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1463274)

  • 21. Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin.
    Stimler NP; Bach MK; Bloor CM; Hugli TE
    J Immunol; 1982 May; 128(5):2247-52. PubMed ID: 6174625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of neuropeptides on adenohypophyseal hormone response to acute stress in male rats.
    Taché Y; Brown M; Collu R
    Endocrinology; 1979 Jul; 105(1):220-4. PubMed ID: 109288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enteral and systemic release of leukotrienes during anaphylaxis of Nippostrongylus brasiliensis-primed rats.
    Moqbel R; King SJ; MacDonald AJ; Miller HR; Cromwell O; Shaw RJ; Kay AB
    J Immunol; 1986 Jul; 137(1):296-301. PubMed ID: 3011907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antinocisponsive effects of neurotensin and neurotensin-related peptides.
    Clineschmidt BV; Martin GE; Veber DF
    Ann N Y Acad Sci; 1982; 400():283-306. PubMed ID: 6963112
    [No Abstract]   [Full Text] [Related]  

  • 25. Pepsin treatment of mammalian plasma generates immunoreactive and biologically active neurotensin-related peptides in micromolar concentrations.
    Carraway RE; Mitra SP; Ferris CF
    Endocrinology; 1986 Oct; 119(4):1519-26. PubMed ID: 2428598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural analysis of sulfido-peptide leukotrienes: application to the design of potent and specific antagonists of leukotriene D4.
    Young RN
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():643-6. PubMed ID: 2546403
    [No Abstract]   [Full Text] [Related]  

  • 27. Xenopsin, neurotensin, neurotensin(8-13) and N-acetyl-neurotensin(8-13) inhibit vascular leakage in rats after tissue injury.
    Gao GC; Wei ET
    J Pharmacol Exp Ther; 1993 May; 265(2):619-25. PubMed ID: 8496813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotensin and antinatriuresis in the conscious rabbit.
    Bloom SR; Peart WS; Unwin RJ
    Br J Pharmacol; 1983 May; 79(1):15-8. PubMed ID: 6871539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Plasma levels of prostaglandins and leukotrienes in vascular diseases].
    Dimich D; Grims R
    Ric Clin Lab; 1989; 19 Suppl 1():75-8. PubMed ID: 2629091
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibitory effects of oxatomide on several activities of SRS-A and synthetic leukotrienes in guinea-pigs and rats.
    Ohmori K; Ishii H; Kubota T; Shuto K; Nakamizo N
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):139-50. PubMed ID: 2862849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of mechanical activity by neurotensin in rat proximal colon: involvement of nitric oxide.
    Mulè F; Serio R
    Am J Physiol; 1997 Aug; 273(2 Pt 1):G491-7. PubMed ID: 9277430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact and mechanisms of action of neurotensin on cardiac contractility in the rat left ventricle.
    Osadchii O; Norton G; Deftereos D; Badenhorst D; Woodiwiss A
    Eur J Pharmacol; 2005 Sep; 520(1-3):108-17. PubMed ID: 16154127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation by gastrin-releasing peptide, neurotensin and DN1417, a novel TRH analog, of dopamine and norepinephrine release from perifused rat hypothalamic fragments in vitro.
    Kabayama Y; Kato Y; Shimatsu A; Yanaihara N; Imura H
    Brain Res; 1986 May; 372(2):394-9. PubMed ID: 3085873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Level of leukotrienes B4 and C4 in the blood of patients with periodic disease].
    Gabrielian ES; Grigorian SV; Davtian DG; Mkhitarian GS; Panosian AG
    Biull Eksp Biol Med; 1990 Sep; 110(9):296-7. PubMed ID: 2176555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of atropine and tetrodotoxin on neurotensin-induced ileal sodium transport in the dog.
    Mailman D
    Br J Pharmacol; 1988 May; 94(1):121-9. PubMed ID: 3401630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of the cardiovascular effects of neurotensin.
    Rioux F; Kérouac R; Quirion R; St-Pierre S
    Ann N Y Acad Sci; 1982; 400():56-74. PubMed ID: 6963116
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of neurotensin-stimulated mast cell secretion and carboxypeptidase A activity by the peptide inhibitor of carboxypeptidase A and neurotensin-receptor antagonist SR 48692.
    Miller LA; Cochrane DE; Feldberg RS; Carraway RE
    Int Arch Allergy Immunol; 1998 Jun; 116(2):147-53. PubMed ID: 9652308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of neurotensin on hypothalamic and pituitary hormone secretion.
    Frohman LA; Maeda K; Berelowitz M; Szabo M; Thominet J
    Ann N Y Acad Sci; 1982; 400():172-82. PubMed ID: 6820241
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolism of leukotriene A4 into C4 by human platelets.
    Pace-Asciak CR; Klein J; Spielberg SP
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():127-33. PubMed ID: 2821752
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of the tissue microenvironment in the regulation of cancer cell motility and invasion.
    Brábek J; Mierke CT; Rösel D; Veselý P; Fabry B
    Cell Commun Signal; 2010 Sep; 8():22. PubMed ID: 20822526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.